J06B immunoglobulin therapy terapia con inmunoglobulina 免疫球蛋白疗法 免疫球蛋白療法 L3
Source: Wikidata · CC0 1.0 Fuente: Wikidata · CC0 1.0 来源:维基数据 · CC0 1.0 來源:維基數據 · CC0 1.0
ATC level L3 · Search this class · Consumer categories
Child classes
J06BAhistaglobulin histaglobulin 组织胺人免疫球蛋白 組織胺人免疫球蛋白J06BBspecific immunoglobulin specific immunoglobulin 特种免疫球蛋白 特種免疫球蛋白J06BCAntibacterial monoclonal antibodies Antibacterial monoclonal antibodies 其它免疫球蛋白类 其它免疫球蛋白類J06BDAntiviral monoclonal antibodies Antiviral monoclonal antibodies Antiviral monoclonal antibodies Antiviral monoclonal antibodies
Active ingredients in this class
40 active ingredients 40 principios activos 40 个活性成分 40 個有效成分
The market codes after a status are the markets where that status is recorded (same codes as the product tables). An ingredient can be on sale in one market and withdrawn in another; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Nirsevimab
J06BD08activeUS GB CA SG CN ES MX TW EUunknownAU HK - Palivizumab
J06BD01activeGB SG TW EUdiscontinuedCA ESwithdrawnESunknownAU HK - Clesrovimab
J06BD10activeUS GB CA SG ES MX EUunknownAU - Hepatitis B Immunoglobulin
J06BBactiveGB CA SG CNdiscontinuedCAunknownAU HK - Bezlotoxumab
J06BC03activeUS GB CNdiscontinuedESwithdrawnEU - Rabies Immunoglobulin
J06BBactiveGB CA CNdiscontinuedCAunknownAU - Cytomegalovirus Immunoglobulin
J06BB09activeGB CA SGunknownAU - Casirivimab
J06BD07activeGBwithdrawnCA ES EU - Sipavibart
J06BD09activeCA EUdiscontinuedESunknownAU - Sotrovimab
J06BD05activeGBwithdrawnCA ES EU - Regdanvimab
J06BBactiveGBdiscontinuedESwithdrawnEUunknownAU - Tixagevimab
J06BD03activeGBdiscontinuedCAwithdrawnES EU - Inmunoglobulina G Humana
J06BA02activeCN ESdiscontinuedES MXwithdrawnES MXunknownMX - Immunoglobulin
J06BA01activeCA SGdiscontinuedCAunknownAU - Immunoglobulin G
J06BA01activeCA SGdiscontinuedCAunknownAU - Obiltoxaximab
J06BC04activeUS CAwithdrawnEU - Tetanus Immunoglobulin
J06BBactiveCNunknownAU - Tetanus Immunoglobulin Human
J06BB02activeGB CAdiscontinuedCA - Varicella-Zoster Immunoglobulin
J06BB03activeGB CAdiscontinuedCA - Bamlanivimab
J06BactiveGBdiscontinuedCA - Inmunoglobulina Anti Citomegalovirus
J06BB09activeESunknownMX - Anti-D
J06BB01activeCAdiscontinuedCA - 白葡萄球菌
J06BBactiveCN - 马破伤风免疫球蛋白(F(ab')2)
J06BBactiveCN - Inmunoglobulina Anti Hepatitis B Humana
J06BB04activeESdiscontinuedESwithdrawnES - 灭活白葡萄球菌
J06BBactiveCN - 细菌溶解产物
J06BBactiveCN - Respiratory Syncytial Virus Immune Globulin Intravenous
J06BA02discontinuedCA - 静注乙型肝炎人免疫球蛋白
J06BBactiveCN - 白葡奈氏菌
J06BBactiveCN - Ansuvimab
J06BD04activeUS - Human Immunoglobulins
J06BB02discontinuedCA - Inmunoglobulina Anti D (Rh)
J06BB01activeES - Inmunoglobulina Antirrábica Humana
J06BB05activeESwithdrawnES - Inmunoglobulina Antitetánica Humana
J06BB02activeES - 泽美洛韦玛佐瑞韦单抗
J06BBactiveCN - 冻干静注乙型肝炎人免疫球蛋白
J06BBactiveCN - Anthrax Immunoglobulin
J06BB19activeCA - Raxibacumab
J06BB18activeUS - Vaccinia Immunoglobulin
J06BB07activeCA
Class names are editorial translations or come from Wikipedia (CC BY-SA 4.0) / Wikidata (CC0); each ATC page lists the exact source, licence and link for every language. Only the ATC code and the WHO hierarchy are authoritative.
Notes & licences
Status badges summarise the product records held for each ingredient (active / discontinued / withdrawn / unknown), and the market codes after each badge show where that status is recorded. Only some registers publish a status column: CA, ES and MX do; AU and HK have no status column and are recorded as unknown; CN, US, GB, TW and SG records are on the register and marked active.
Class and category names are editorial or AI-assisted translations; only the ATC code and the WHO hierarchy are authoritative.
ATC codes and hierarchy reference the WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (copyright WHOCC; the index itself is not reproduced). Ingredient/strength facts come from the regulator records listed on About.